2013
DOI: 10.1001/jamaneurol.2013.698
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Analysis of Inherited Leukodystrophies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
44
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 79 publications
(48 citation statements)
references
References 23 publications
3
44
1
Order By: Relevance
“…The median age of onset is 42 ± 13 years (range 8-78) with a disease duration of 5 ± 7 (range 1-34) years that is unrelated to the time of onset (Ahmed et al, 2013; Freeman et al, 2009; Guerreiro et al, 2013; Hoffmann et al, 2014; Karle et al, 2013; Kinoshita et al, 2014; Kleinfeld et al, 2013; Kondo et al, 2013; Konno et al, 2014; Mitsui et al, 2012; Rademakers et al, 2011; Sundal et al, 2012; Van Gerpen et al, 2008; Wider et al, 2009). Symptoms may vary according to gender (Hoffmann et al, 2014), and clinical presentation is variable.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The median age of onset is 42 ± 13 years (range 8-78) with a disease duration of 5 ± 7 (range 1-34) years that is unrelated to the time of onset (Ahmed et al, 2013; Freeman et al, 2009; Guerreiro et al, 2013; Hoffmann et al, 2014; Karle et al, 2013; Kinoshita et al, 2014; Kleinfeld et al, 2013; Kondo et al, 2013; Konno et al, 2014; Mitsui et al, 2012; Rademakers et al, 2011; Sundal et al, 2012; Van Gerpen et al, 2008; Wider et al, 2009). Symptoms may vary according to gender (Hoffmann et al, 2014), and clinical presentation is variable.…”
Section: Discussionmentioning
confidence: 99%
“…Patients often present with sensorimotor and neuropsychiatric symptoms, including depression, behavioral changes, spastic paraplegia, dementia and seizures, leading to frequent and diverse clinical misdiagnoses. The initial symptoms progress to dementia and death (Axelsson et al, 1984; Guerreiro et al, 2013; Marotti et al, 2004; Sundal et al, 2012; Wider et al, 2009). By MRI, ALSP is characterized by patchy cerebral white matter lesions, often initially asymmetrical, but becoming confluent and symmetrical with disease progression (Freeman et al, 2009; Konno et al, 2014; Sundal et al, 2012; Van Gerpen et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…The screening of larger cohorts might lead to the identification of cases carrying the repeat expansion or pathogenic variants in common FTD genes. The screening for mutations in other uncommon FTD genes such as the charged multivesicular body protein 2B ( CHMP2B ) [42], FUS [43, 44], dynactin ( DCTN1 ) [45], sequestosome 1 ( SQSTM1 ) [46], colony-stimulating factor 1 receptor ( CFS1R ) [47], triggering receptor expressed on myeloid cells ( TREM2 ) [48], ubiquilin-2 ( UBQLN2 ) [49] and heterogeneous nuclear ribonucleoprotein A2B1 ( hnRNPA2B1 ) [50] might be the next step to perform. Ultimately, next generation sequencing methods seem like the efficient strategy to unravel the genetic origin of FTD in our cohort.…”
Section: Discussionmentioning
confidence: 99%
“…2 ALSP is increasingly recognized as one of the most common causes of adult-onset inherited leukoencephalopathy. 3 ALSP diagnosis is still challenging because of the multiple presentations that can mimic frontotemporal lobar degeneration (FTLD), atypical parkinsonism, CADASIL, or primary-progressive MS. 1,[3][4][5] Indeed, initial descriptions of ALSP included lateonset psychiatric and cognitive impairment with MR imaging frontal white matter changes and atrophy. Following the genetic characterization of the disease, more distinctive imaging findings have been identified, including deep punctate calcifications, persistent DWI small diffusion-restricted lesions, and corpus callosum thinning.…”
mentioning
confidence: 99%